Aurinia Pharmaceuticals Inc.

Ownership Transactions Reported by 24 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	13	-374K	100%	$5.65	-$2.11M
Net	-13	-374K	-100%		-$2.11M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Kevin Tang	Director	$38.4M			Sep 12, 2024
Peter Greenleaf	Chief Executive Officer, Director	$8.52M	-$711K	-7.7%	Mar 6, 2024
Matthew Maxwell Donley	EVP, Ops & Strategy	$3.22M	-$224K	-6.51%	Mar 6, 2024
Michael Robert Martin	Chief Business Officer	$2.92M			Mar 2, 2023
Joseph M. Miller	Chief Financial Officer	$2.78M	-$195K	-6.56%	Mar 6, 2024
Stephen P. Robertson	EVP, General Counsel	$2.49M	-$323K	-11.5%	Mar 6, 2024
Scott Habig	Chief Commercial Officer	$2.42M	-$283K	-10.5%	Aug 6, 2024
Volker Knappertz	EVP, Research and Development	$1.95M	-$168K	-7.94%	Feb 27, 2024
Neil Solomons	Chief Medical Officer	$1.02M			Mar 2, 2022
George M. Milne Jr	Director	$887K			May 18, 2023
Robert Bindert Huizinga	EVP of Research	$781K			Mar 2, 2022
Greg Keenan	Chief Medical Officer	$592K			Nov 7, 2024
David R.W. Jayne	Director	$255K	-$28.4K	-10%	May 21, 2024
Daniel Billen	Director	$162K	-$30.1K	-15.7%	May 21, 2024
Massimilano Colao	Chief Commercial Officer	$152K			Mar 2, 2022
Joseph P. Hagan	Director	$135K			May 18, 2023
Jeffrey A. Bailey	Director	$113K	-$38.4K	-25.4%	Nov 8, 2024
Karen L. Smith	Director	$107K	-$44.2K	-29.3%	Nov 8, 2024
R. Hector MacKay-Dunn	Former Director	$107K	-$32.3K	-23.2%	Sep 9, 2024
Brinda Balakrishnan	Director	$101K	-$2.99K	-2.88%	May 21, 2024
Jill Leversage	Director	$74.1K	-$32.2K	-30.3%	May 21, 2024
Timothy P. Walbert	Director				May 18, 2022
Robert T. Foster	Director				Sep 21, 2023
Craig Johnson	Director				Nov 7, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.